Related Experiment Video
Updated: May 21, 2025

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Cholera in Lebanon: A new epidemic in an on-going endemic of weak infrastructure
Nada M Melhem1, Mirna Bou Hamdan1
1Medical Laboratory Sciences Program, Division of Health Professions, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Abstract:
On October 6, 2022, the WHO declared the start of a cholera outbreak in Lebanon, the first cholera outbreak since 1993. The aim of this review is to advance the evolution of the cholera epidemic in Lebanon and its underlying risk factors. Early during the outbreak, the majority of confirmed cases were reported among displaced Syrian refugees living in suboptimal conditions; however, three weeks following the former, cholera spread nationwide. This spread was exacerbated by the decline in water treatment investments, lack of electric supply in water treatment plants and collapsing healthcare and economic infrastructures. Addressing the structural root causes is urgently needed in order to mitigate the re-emergence of cholera and other infectious diseases spreading among vulnerable populations and thus threatening national and regional health security.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Sexually Transmitted Infections
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Stages of Infection

